Amphastar Pharmaceuticals (AMPH) Assets Growth (3y) (2016 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Assets Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.60 Bn | 38.95 Bn | 2.15 Bn |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 490.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.86 Mn | 704.74 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.03 Mn | 358.78 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 179.86 Mn | 179.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.16% |
| Mar 31, 2026 | 28.67% |
| Dec 31, 2025 | 29.98% |
| Sep 30, 2025 | 31.86% |
| Jun 30, 2025 | 30.69% |
| Mar 31, 2025 | 31.44% |
| Dec 31, 2024 | 32.93% |
| Sep 30, 2024 | 33.35% |
| Jun 30, 2024 | 30.85% |
| Mar 31, 2024 | 34.59% |
| Dec 31, 2023 | 33.83% |
| Sep 30, 2023 | 36.03% |
| Mar 31, 2023 | 10.54% |
| Dec 31, 2022 | 8.13% |
| Sep 30, 2022 | 7.46% |
| Jun 30, 2022 | 6.37% |
| Mar 31, 2022 | 9.55% |
| Dec 31, 2021 | 9.35% |
| Sep 30, 2021 | 10.68% |
| Jun 30, 2021 | 13.81% |